Nurse Practitioner, Family · Dallas, TX
NPI
1265942965
Since 2017
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
3500 Oak Lawn Ave Ste 700
Dallas, TX, 75219
Phone (214) 521-0100
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$1.3M
1,743 prescriptions
Company payments, 2025
$2,157
From 14 companies
Medicare prescription drug claims, 2024
In 2024, the drug Chad M Crager prescribed most often to Medicare patients was Atorvastatin Calcium, with 120 prescriptions and refills. In total Chad M Crager wrote 1,743 Medicare prescriptions that cost $1.3M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-04-08.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Atorvastatin Calcium Generic | 120 | 359 | 37 | $718 |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 63 | 63 | Under 11 | $249K |
| Descovy Emtricitabine/Tenofov Alafenam | 59 | 59 | Under 11 | $138K |
| Dovato Dolutegravir Sodium/Lamivudine | 58 | 58 | Under 11 | $170K |
| Rosuvastatin Calcium Generic | 56 | 168 | 19 | $330 |
| Lisinopril Generic | 55 | 155 | 15 | $332 |
| Trazodone Hcl Generic | 54 | 108 | 13 | $136 |
| Finasteride Generic | 36 | 94 | 12 | $485 |
| Tivicay Dolutegravir Sodium | 36 | 40 | Under 11 | $116K |
| Gabapentin Generic | 36 | 60 | Under 11 | $458 |
| Clonazepam Generic | 33 | 41 | Under 11 | $133 |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 33 | 41 | Under 11 | $146K |
| Metformin Hcl Generic | 29 | 81 | Under 11 | $157 |
| Ozempic Semaglutide | 29 | 42 | Under 11 | $41K |
| Prezcobix Darunavir/Cobicistat | 29 | 37 | Under 11 | $89K |
Brand drugs: 480 claims; generic drugs: 1,251 claims; opioid claims: 14.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Chad M Crager $2,157 ($2,157 in general payments such as food, travel and fees) from 14 companies. The largest payer was ViiV Healthcare Company with $769.
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company GSK | 33 | $769 |
| Gilead Sciences, Inc. GILD | 12 | $538 |
| Merck Sharp & Dohme LLC MRK | 10 | $239 |
| EMD Serono, Inc. MRK.DE | 8 | $178 |
| Novo Nordisk Inc NVO | 5 | $89.22 |
| Theratechnologies Inc. THTX | 3 | $82.06 |
| Abbvie Inc. ABBV | 3 | $69.06 |
| Pfizer Inc. PFE | 2 | $52.46 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 2 | $32.26 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 1 | $25.45 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.